Growing need for early detection of infectious diseases and rapidly advancing global healthcare infrastructure boost market growth
The global clinical microbiology market size is expected to reach USD 6.6 billion by 2028 at a CAGR of 6.7%, according to the latest report by Reports and Data. The market is expected to gain robust traction in the coming years due to rising prevalence of infectious diseases worldwide, growing need for early and accurate disease diagnosis, and increasing R&D activities to develop pathogen-specific diagnostic kits. In addition, growing adoption of advanced genomic techniques for disease detection, increased availability of low-cost clinical microbiology products, and growing use of clinical microbiology products across clinical diagnostic centers and research laboratories are other factors fueling the growth of the global clinical microbiology market.
Clinical microbiology is the study of microbes that cause severe infections in the human body. It involves accurate diagnosis of infectious diseases using bodily fluid samples to identify microbes that cause the infection. Clinical microbiology aids in rapid diagnosis of pathogens and ensures effective administration of antibiotics to enhance treatment results. It uses several advanced diagnostic methods, such as MALDI–TOF mass spectrometry, real-time genome sequencing, and phenotypic microarrays, for sampling and analysis processes. The global clinical microbiology market growth is further driven by rapid development of the healthcare infrastructure worldwide.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/4032
Market Dynamics:
Growth in the historic period resulted from the rapid growth in the elderly population, strong economic growth in emerging markets, decline in oil prices, and health insurance reforms globally. Factors that negatively affected growth in the historic period were low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes.
Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth. Factors that could hinder the growth of this market in the future are rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations.
Regional Outlook:
North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
Order this Reports @ https://www.reportsanddata.com/report-pricing/4032
Competitive Outlook:
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing the adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology. Players adopted strategies in the healthcare industry include acquiring companies in similar industries to expand their presence and focusing on offering quality products and services.
The competitive landscape section of the report discusses in detail the company overview, product and services portfolio, business expansion plans, production and manufacturing capacity, financial standing, and global market position. It further sheds light on the recent mergers and acquisitions, collaborations, partnerships, corporate and government deals, agreements, and product launches.
Top companies operating in the market and profiled in the report include:
Merck KGaA, BioMérieux, 3M, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Bruker Corporation, Hologic Inc., Bio-Rad Laboratories Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., QIAGEN, Arrow Diagnostics, Agilent Technologies, Memmert, Hardy Diagnostics, NEOGEN Corporation, Biotechnology Solutions, Liofilchem, Shimadzu Corporation, Rapid Micro Biosystems, TCS Biosciences, New Horizons, OpGen, and Vacutest Kima
Further, the report segments the Clinical Microbiology market on the basis of product types, applications, end-use industries, and technology among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Clinical Microbiology Market Segmentation:
By Laboratory Instrument Type (Revenue, USD Billion; 2018-2028)
- Incubators
- Gram Stainers
- Petri Dish Fillers
- Microbial Air Samplers
- Blood Culture Systems
- Autoclave Sterilizers
- Bacterial Colony Counters
- Anaerobic Culture Systems
- Microbial Analyzers
- Molecular Diagnostics Instruments
- Mass Spectrometers
- Microscopes
- Others
By Reagent Type (Revenue, USD Billion; 2018-2028)
- Pathogen-specific Kits
- General Reagents
- Others
By Disease Type (Revenue, USD Billion; 2018-2028)
- Bloodstream Infections
- Respiratory Diseases
- Gastrointestinal Diseases
- Sexually Transmitted Diseases
- Periodontal Diseases
- Urinary Tract Infections
- Others
By Application (Revenue, USD Billion; 2018-2028)
- Pharmaceutical Applications
- Food Testing Applications
- Clinical Applications
- Energy Applications
- Environmental Applications
- Chemical & Material Manufacturing Applications
- Others
By End-user (Revenue, USD Billion; 2018-2028)
- Hospitals & Diagnostics Centers
- Custom Laboratory Service Providers
- Academic & Research Institutes
- Others
Regional Analysis covers:
· North America
o U.S.
o Canada
o Mexico
· Europe
o Germany
o Italy
o U.K.
o Rest of EU
· Asia Pacific
o India
o China
o Japan
o South Korea
o Rest of APAC
· Latin America
o Brazil
o Argentina
o Rest of Latin America
· Middle East & Africa
o Saudi Arabia
o South Africa
o U.A.E
o Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4032
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized to meet your requirements.
Explore More Industry Research by Reports and Data:
Bone Growth Stimulator Market @ https://www.biospace.com/article/bone-growth-stimulator-market-trends-2022-product-launches-and-research-for-advanced-bone-stimulation-technologies-/
Magnetic Resonance Imaging (MRI) Market @ https://www.biospace.com/article/magnetic-resonance-imaging-mri-market-growth-2022-2028-increase-in-demand-for-magnetic-resonance-imaging-for-neurological-procedures-is-driving-factor-of-market/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
The global clinical microbiology market size is expected to reach USD 6.6 billion by 2028 at a CAGR of 6.7%, according to the latest report by Reports and Data.
The market is expected to gain robust traction in the coming years due to rising prevalence of infectious diseases worldwide, growing need for early and accurate disease diagnosis, and increasing R activities to develop pathogen-specific diagnostic kits.
In addition, growing adoption of advanced genomic techniques for disease detection, increased availability of low-cost clinical microbiology products, and growing use of clinical microbiology products across clinical diagnostic centers and research laboratories are other factors fueling the growth of the global clinical microbiology market.Clinical microbiology is the study of microbes that cause severe infections in the human body.
Clinical microbiology aids in rapid diagnosis of pathogens and ensures effective administration of antibiotics to enhance treatment results.
It uses several advanced diagnostic methods, such as MALDI–TOF mass spectrometry, real-time genome sequencing, and phenotypic microarrays, for sampling and analysis processes.
The global clinical microbiology market growth is further driven by rapid development of the healthcare infrastructure worldwide.Top Companies Profiled in the Report Include: Merck KGaA, BioMérieux, 3M, Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, Bruker Corporation, Hologic Inc., Bio-Rad Laboratories Inc., Roche Diagnostics, Thermo Fisher Scientific Inc., QIAGEN, Arrow Diagnostics, Agilent Technologies, Memmert, Hardy Diagnostics, NEOGEN Corporation, Biotechnology Solutions, Liofilchem, Shimadzu Corporation, Rapid Micro Biosystems, TCS Biosciences, New Horizons, OpGen, and Vacutest KimaGet a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4032Market Overview: The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness.
Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments.What the Market Looks Like?According to research report the clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018 growing at a CAGR of 6.4% during forecast period.
Asia Pacific market is expected to grow at the highest CAGR from 2018 to 2023.The global clinical microbiology market is segmented by product, disease area, end user, and region.
On the basis of products, the clinical microbiology market is segmented into instruments, and reagents.Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367• The reagents product segment is expected to grow at the fastest rate during the forecast period.
The high growth of reagents segment is attributed to the high prevalence of infectious diseases across major markets (resulting in a growing number of clinical diagnostic procedures), growing trend of reagent rental agreements along with instrument sales, and an increasing number of life science researches in the field of specific reagents for targeted infectious disease diagnosis & treatment, especially across emerging countries.• The instruments product segment is further subsegmented into laboratory instruments (incubators, gram stainers, autoclave sterilizers, bacterial colony counters, microbial air samplers, blood culture counters, microbial culture systems, anaerobic culture systems, petri dish fillers, and other laboratory instruments) and microbiology analyzers (molecular diagnostic instruments, advanced microscopes, and mass spectrometers).
The microbiology analyzer segment is expected to grow at higher CAGR during the forecast period.• The reagents product segment is further subsegmented into pathogen-specific kits and general reagents.
The pathogen-specific kits segment is expected to grow at higher CAGR during the forecast period.
